Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Sebaceous gland carcinoma is a rare but aggressive cancer that starts in oil-producing glands of the skin. Around the eye, it often arises from meibomian glands in the eyelids, which is why many cases appear as an eyelid lump. The tumor can look like a chalazion or chronic eyelid inflammation, which can delay diagnosis. Early biopsy and complete removal are important because the cancer can recur or spread.
read more about sebaceous gland carcinoma ...The exact cause is not always known, but risk rises with age and is higher in older adults. Prior radiation exposure and immune suppression can increase risk in some cases. Some tumors are linked with Muir-Torre syndrome, which is associated with DNA mismatch repair defects and internal cancers. Around the eyelid, the large number of sebaceous glands in the upper lid contributes to the higher frequency there. Because benign lesions can look similar, persistent or recurrent eyelid lumps deserve evaluation.
A painless, firm eyelid nodule is a common presentation, often in the upper eyelid. The lesion can look yellowish, can cause thickening of the lid margin, and can lead to lash loss near the tumor. Some cases present as chronic, one-sided blepharitis or conjunctivitis that does not improve with usual treatment. Recurrent chalazion in the same location is a classic warning sign. Any lesion that grows, ulcerates, bleeds, or keeps returning should be checked.
Diagnosis requires a biopsy, since the clinical appearance can mimic benign eyelid disease. Pathology can identify sebaceous differentiation and can also check for pagetoid spread, where tumor cells spread along surface epithelium. When pagetoid spread is suspected, map biopsies of the conjunctiva can be used to define tumor extent. The clinician also evaluates regional lymph nodes and overall skin for additional lesions, based on risk features. Further workup can include discussion of mismatch repair testing or systemic evaluation when Muir-Torre syndrome is a concern.
Surgical removal with margin control is the main treatment, commonly using Mohs micrographic surgery or wide excision with careful pathologic margin assessment. Reconstruction is planned to restore eyelid function and protect the ocular surface after tumor removal. In select higher-risk cases, lymph node evaluation or imaging is considered based on tumor size, location, and pathology findings. Radiation therapy can be used when surgery is not possible or as adjunct therapy in specific situations. Long-term follow-up is important because recurrence can occur and early detection improves outcomes.
Sebaceous gland carcinoma often looks like a chalazion, but warning signs include recurrence in the same spot, lash loss, and persistent lid thickening. A typical stye or chalazion improves with time and treatment, while carcinoma does not resolve. Unilateral chronic blepharitis that does not respond to care can also be a clue. A biopsy is the only way to confirm the diagnosis.
Yes, it can be serious because it can invade locally and can spread to lymph nodes or distant sites. Delay in diagnosis increases risk of deeper invasion and recurrence. Early detection and complete removal improve prognosis. Follow-up after treatment is part of safe care.
Yes, metastatic spread can occur, especially with larger tumors or delayed diagnosis. Regional lymph nodes are a common route, so clinicians check nodes during evaluation and follow-up. Spread risk depends on tumor features seen on pathology. Early treatment lowers the chance of spread.
Sebaceous Carcinoma. EyeWiki. https://eyewiki.org/Sebaceous_Carcinoma. Date Accessed February 4, 2026.
Sebaceous carcinoma. National Cancer Institute (NCI) Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sebaceous-carcinoma. Date Accessed February 4, 2026.
Sebaceous carcinoma. DermNet NZ. https://dermnetnz.org/topics/sebaceous-carcinoma. Date Accessed February 4, 2026.
Sebaceous carcinoma. Pathology Outlines. https://www.pathologyoutlines.com/topic/skintumornonmelanocyticsebaceouscarcinoma.html. Date Accessed February 4, 2026.
Diagnosis and Management of Sebaceous Carcinoma of the Eyelid. American Academy of Ophthalmology (EyeNet). https://www.aao.org/eyenet/article/diagnosis-management-of-sebaceous-carcinoma-of-eyelid. Date Accessed February 4, 2026.